American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
ELITE PHARMACEUTICALS INC /NV/
$0.37
-4.19%
OTC: ELTP · 15-min delayed
$84.0MRevenue · FY2025
-$4.3MNet income
ELTPOTC
About ELITE PHARMACEUTICALS INC /NV/
ELITE PHARMS INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2025
- $84.0M
- Net income
- -$4.3M
- Total assets
- $96.4M
Source: SEC EDGAR · updated Jun 7, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Reported a net loss of $4.3M in FY2025.
- Trading 52% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ELITE PHARMACEUTICALS INC /NV/.
Write a review
Newsroom
News about ELITE PHARMACEUTICALS INC /NV/
The Zacks Analyst Blog Highlights Danaher, Morgan Stanley, Pfizer, Elite Pharmaceuticals and Oil-Dri - Zacks Investment Research
Elite Pharmaceuticals' (ELTP) FY24 Earnings Up, Gross Margin Down
News & sentiment via Polygon.io
Explore
Browse all →
